NOACS VERSUS WARFARIN USE IN THE MANAGEMENT OF ATRIAL FIBRILLATION PATIENTS
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)33734-8
Abstract: Background: Novel oral anti-coagulation therapies (NOAC) have now become the standard of care treatment among patients at risk of stroke with non-valvular atrial fibrillation (AF) in the US. NOAC use has significantly increased since the… read more here.
Keywords: atrial fibrillation; fibrillation; noacs versus; versus warfarin ... See more keywords